Gilberto Lopes, Chief of the Division of Medical Oncology at the Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“November is Lung Cancer Awareness Month.
I told the story of my grandmothers and my parents. I did not tell the story of my great-uncle Fabio – our family’s favorite uncle.
He developed chronic myeloid leukemia at a time when imatinib already existed, but it was not available in Brazil’s public health system, the SUS. He fought the disease for about a year, and he died because of lack of access to a drug that already existed.
That is why the second half of my career has been about access – health economics, policy, and changing the way we deliver health care and the way we work on cancer control.
From my OncoDaily TV interview, on why access to medicines matters.”
Proceed to the video attached to the post:
You may also be interested in:
Gilberto Lopes on Ivonescimab and the FDA Decision: When Is Progression-Free Survival Enough?
Jasmine Kamboj: The Evolution of ASCO’s Volunteer-Led Community of Practice on Health Policy